John J. Boniface - May 4, 2022 Form 4 Insider Report for SERA PROGNOSTICS, INC. (SERA)

Role
Chief Scientific Officer
Signature
/s/ Benjamin G. Jackson, Attorney-in-fact
Stock symbol
SERA
Transactions as of
May 4, 2022
Transactions value $
-$1,440
Form type
4
Date filed
5/4/2022, 06:15 PM
Previous filing
May 3, 2022
Next filing
May 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SERA Class A Common Stock Options Exercise $730 +1K +1.26% $0.73 80.2K May 4, 2022 Direct
transaction SERA Class A Common Stock Sale -$2.17K -1K -1.25% $2.17 79.2K May 4, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SERA Stock Option (right to buy) Options Exercise $0 -1K -20.64% $0.00 3.84K May 4, 2022 Class A Common Stock 1K $0.73 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2021.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.11 to $2.30, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F3 The shares subject to this option are fully vested and exercisable.